The application provides peptides that interact with the inhibitory
domains of the myelin proteins Nogo, TNR, and MAG. These may be used in
the treatment of CNS damage, and for the development of further
treatments. Also provided are methods and materials for immunizing
subjects against the inhibitory domains of the myelin proteins, for the
treatment of CNS damage.